Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/DIPROGENTA 0,5 mg/g + 1 mg/g crema

Approved

STANDARD

DIPROGENTA 0,5 mg/g + 1 mg/g crema

Organon Healthcare Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 4, 2025
Approval ID: 039b6e9145573f55
Company: Organon Healthcare Gmbh
Type: Standard

Approval Details

Approval Id: 039b6e9145573f55
Drug Cima Aemps Name: DIPROGENTA 0,5 mg/g + 1 mg/g crema
Register Number: 15937IP
Holder Company Name: Organon Healthcare Gmbh
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/organon-healthcare-gmbh
Authorization Date: 2025-11-04
Dosage Form: CREMA
Dose: 0,5 mg/g + 1 mg/g
Route Of Administration: USO CUTÁNEO
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Organon Healthcare Gmbh
Company Detail Path: /organization/organon-healthcare-gmbh

Company Information

Pharmaceutical Company Name: Organon Healthcare GmbH
Country Name: Germany
City Name: münchen,bayern,country_de
Address: Pestalozzistr. 31

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 4, 2025

Approval ID

039b6e9145573f55

Type

Standard

Back to CIMA-AEMPS Approvals

DIPROGENTA 0,5 mg/g + 1 mg/g crema - CIMA-AEMPS Drug Approval Details